K
Exchange
—
Entity type
operating
Fiscal year end
Mar 31
Headquarters
DE
Recent Filings
- 43.1 KBK-V Pharmaceutical CoMar 5, 5:27 PM ET·0001187302-14-000001
- 43.1 KBK-V Pharmaceutical CoMar 5, 5:04 PM ET·0001521123-14-000001
- 43.1 KBK-V Pharmaceutical CoMar 5, 4:59 PM ET·0001589045-14-000001
- 43.0 KBK-V Pharmaceutical CoMar 5, 4:55 PM ET·0001588987-14-000001
- 43.1 KBK-V Pharmaceutical CoMar 5, 4:46 PM ET·0001590794-14-000001
- 43.1 KBK-V Pharmaceutical CoMar 5, 4:42 PM ET·0001240547-14-000001
- 43.1 KBK-V Pharmaceutical CoMar 5, 4:37 PM ET·0001589937-14-000001
- 43.0 KBK-V Pharmaceutical CoMar 5, 4:29 PM ET·0001405104-14-000001
- 43.1 KBK-V Pharmaceutical CoMar 5, 4:17 PM ET·0001410677-14-000001
- 48.1 KBK-V Pharmaceutical CoNov 20, 5:49 PM ET·0001123292-13-001613
Insiders
10- ANDERSON MICHAEL SHANNONCEO, ETHEX Corporation
- Aronson Jeffrey10% Owner
- BALDINI ROBERT EDirector
- BELLIN JEAN MDirector
- BENTLEY GREGORY SMITHDirector, Senior VP - Law
- BLESER RITAPres. - Pharmaceutical Div.
- Brady Paul TPresident, PDI
- CARLIE KEVIN SDirector
- Centerbridge Partners, L.P.10% Owner
- CHIBNALL RICHARD HVice President/Finance
Tickers
No tickers on record
Addresses
business
16640 CHESTERFIELD GROVE ROAD SUITE 200
CHESTERFIELD, MO, 63005
mailing
16640 CHESTERFIELD GROVE ROAD SUITE 200
CHESTERFIELD, MO, 63005
Former Names
- KV PHARMACEUTICAL CO /DE/2013-09-24